Skip to content
Dose Brief
Menu
No. 183 on the board · Grade C

Harbor review

Harbor is a physician-led telehealth platform offering compounded semaglutide (from $99/mo) and compounded tirzepatide (from $149/mo) — among the lowest headline prices in the market.

Visit Harbor Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $99/mo (starting dose, compounded)
Tirzepatide
From $149/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only
On the trackerNewnew to the tracker, no prior readingNew to the tracker on 1 August 2026. The published line reads From $99/mo (starting dose, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

The scorecard

Harbor scored on our six Brief Score factors. See the methodology.

Price Stability36/100
Supply Reliability83/100
Transparency72/100
Access Breadth50/100
Clinical Oversight94/100
Track Record78/100

What we like

  • Compounded semaglutide from $99/mo and tirzepatide from $149/mo — among the lowest headline prices in the market
  • LegitScript certified with 4.7-star rating, 94.6% success rate, and 10,000+ verified members
  • 24/7 physician access with ongoing consultations, dosage adjustments, and free discreet shipping
  • 12-Month Money Back Guarantee if you don't reach your weight-loss goal
  • HSA/FSA eligible; no hidden fees, no insurance billed

The caveats

  • Compounded medications are not FDA-approved; compounding pharmacy names not publicly disclosed
  • Dietitian support offered only post-program (maintenance phase), not during active treatment
  • State-specific consultation types vary; nationwide availability unconfirmed for all states
  • No labs disclosed; patient portal is a third-party platform (mdintegrations), not native
  • Newer brand; success rate and member counts are on-site claims, not third-party verified

The brief

Best for: Readers who want adults seeking the lowest-cost compounded GLP-1 with physician oversight and a 12-month money-back guarantee. Harbor is a physician-led telehealth platform offering compounded semaglutide (from $99/mo) and compounded tirzepatide (from $149/mo) — among the lowest headline prices in the market.

Ranked #183 of 495 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Closest on the board

The desks scoring nearest Harbor — the realistic shortlist if you're weighing it.

Weighing Harbor against one desk in particular? We file it head to head with our top-ranked pick in CoreAge Rx vs Harbor, and every desk that outranks it is listed on the Harbor alternatives board.

More desks we track (24)

464 more are filed too — see every desk we track, ranked.

Pricing, states and verification reflect Harbor's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Harbor's site. Not medical advice; see our disclosure.

← Back to all rankings